How is the Portal Hypertension Management Market Poised for Growth: Trends and Opportunities Through 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the portal hypertension management market grown in recent years?
The market for managing portal hypertension has witnessed robust growth in the past few years. The market size is projected to rise from $3.07 billion in 2024 to $3.28 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth in the historical period include rising incidence of liver diseases, increase in the elderly population, awareness campaigns and screening programs, economic impact of liver diseases, authorization of new drugs and therapies, and enhancements achieved in diagnostic techniques.
How is the portal hypertension management market size expected to evolve during the forecast period?
The portal hypertension management market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising investment in healthcare infrastructure, broader health insurance coverage, favorable regulatory environments and expedited approval processes, ongoing r&d activities focused on understanding the pathophysiology of portal hypertension, and remote monitoring technologies will facilitate continuous patient management. Major trends in the forecast period include growing adoption of telemedicine, continued advancements in medical technology, such as bio-engineered liver tissue, growth in personalized medicine, development of targeted therapies tailored to individual patient profiles, improved diagnostic methods, including non-invasive imaging technologies like elastography.
Get your portal hypertension management market report here!
Which key drivers are propelling the portal hypertension management market’s growth?
The escalating occurrence of liver-related ailments such as hepatitis is anticipated to fuel the progression of the portal hypertension management market. Liver disease encompasses a spectrum of illnesses disrupting the liver’s anatomy or functioning, generally resulting in symptoms like jaundice, tiredness, and stomach discomfort, induced by viral infections, excessive alcohol intake, or metabolic abnormalities. These ailments are cropping up because of factors such as alcohol intake, viral hepatitis infections, obesity-induced fatty liver disease, and metabolic irregularities. Treatment for portal hypertension in patients with liver disease primarily aims to relieve pressure in the portal vein system, helping to curtail issues like variceal bleeding, ascites, and hepatic encephalopathy, thereby enhancing the results for patients. For example, Cancer Australia, a government cancer agency based in Australia, reported roughly 2,905 new instances of liver cancer diagnosed in Australia in 2022 (2,113 males and 792 females) in September 2022. Moreover, it’s predicted that the possibility of developing liver cancer by the age of 85 will be 1 in 103 (or 0.97%) in 2022, 1 in 70 or 1.4% for men, and 1 in 195 or 0.51% for women. As a result, the rising incidence of liver diseases is propelling the growth of the portal hypertension management market.
What are the market segments in the portal hypertension management industry?
The portal hypertension management market covered in this report is segmented –
1) By Treatment Type: Medications, Non-Surgical Procedures, Surgery
2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Other Procedure Types
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Beta-Blockers, Vasodilators, Diuretics, Antibiotics, Other Medications
2) By Non-Surgical Procedures: Endoscopic Variceal Ligation (EVL), Endoscopic Sclerotherapy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Balloon Occlusion
3) By Surgery: Liver Transplantation, Portosystemic Shunt Surgery, Surgical Decompression Of Portal Vein, Other Surgical Procedures
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16515&type=smp
Which leading companies are shaping the growth of the portal hypertension management market?
Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.
What are the key trends shaping the future of the portal hypertension management market?
Top organizations in the portal hypertension management market are implementing innovative minimally invasive tools to boost treatment results and decrease operational hazards. These minimally invasive devices are designed to carry out procedures with little disruption to nearby tissues, usually via small incisions or natural bodily openings. Taking an example from November 2023, Medtronic Plc, a medical device producer based in the USA, received clearance from the U.S. Food and Drug Administration (FDA) for their Symplicity Spyral renal denervation (RDN). This is a minimally invasive tool used to treat hypertension. This groundbreaking method uses radiofrequency energy to target the nerves located near the kidneys, effectively soothing them to better manage hypertension.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16515
Which geographic areas are influencing the growth of the portal hypertension management market?
North America was the largest region in the portal hypertension management market in 2023. The regions covered in the portal hypertension management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Airway Management Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/airway-management-devices-global-market-report
Digital Diabetes Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
